Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Guerini-Rocco

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
The Journal of Pathology|January 26, 2016
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutationsElena Guerini-Rocco, Salvatore Piscuoglio, Charlotte K Y Ng, et al.
Cancers|September 28, 2023
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma PatientsLisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, et al.
Breast (Edinburgh, Scotland)|July 4, 2021
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsFabio Conforti, Laura Pala, Eleonora Pagan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatmentLuigi A De Vitis, Gabriella Schivardi, Susanna Delfrati, et al.
The Journal of Pathology|May 27, 2015
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating studyElena Guerini-Rocco, Zsolt Hodi, Salvatore Piscuoglio, et al.
Cancers|June 21, 2020
Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical ReviewGiovanni Corso, Giacomo Montagna, Joana Figueiredo, et al.
Pathologica|April 9, 2026
<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 6, 2016
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancerNicola Fusco, Felipe C Geyer, Maria R De Filippo, et al.
Cancers|September 28, 2021
Reproducibility of mRNA-Based Testing of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, and <i>MKI67</i> Expression in Invasive Breast Cancer-A Europe-Wide External Quality AssessmentRamona Erber, Arndt Hartmann, Peter Andreas Fasching, et al.
JAMA Network Open|April 23, 2024
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer PhenotypeGiovanni Corso, Elena Marino, Cristina Zanzottera, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Pathology|January 26, 2016
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutationsElena Guerini-Rocco, Salvatore Piscuoglio, Charlotte K Y Ng, et al.
Cancers|September 28, 2023
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma PatientsLisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, et al.
Breast (Edinburgh, Scotland)|July 4, 2021
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsFabio Conforti, Laura Pala, Eleonora Pagan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatmentLuigi A De Vitis, Gabriella Schivardi, Susanna Delfrati, et al.
The Journal of Pathology|May 27, 2015
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating studyElena Guerini-Rocco, Zsolt Hodi, Salvatore Piscuoglio, et al.
Cancers|June 21, 2020
Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical ReviewGiovanni Corso, Giacomo Montagna, Joana Figueiredo, et al.
Pathologica|April 9, 2026
<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 6, 2016
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancerNicola Fusco, Felipe C Geyer, Maria R De Filippo, et al.
Cancers|September 28, 2021
Reproducibility of mRNA-Based Testing of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, and <i>MKI67</i> Expression in Invasive Breast Cancer-A Europe-Wide External Quality AssessmentRamona Erber, Arndt Hartmann, Peter Andreas Fasching, et al.
JAMA Network Open|April 23, 2024
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer PhenotypeGiovanni Corso, Elena Marino, Cristina Zanzottera, et al.
Pageof 16